Learn More About Silence’s Broad RNAi Therapeutic Platform
 
 

Review One of the Industry’s Broadest RNAi Clinical Pipelines
 
 
     
      Webcast - Corporate Update
Rodman & Renshaw 6th Annual Global Healthcare Conference - May 18, 2010

14.07.10
Silence Therapeutics and AstraZeneca Extend siRNA Development Collaboration

07.07.10
Silence Therapeutics Expands RNAi Structural Modification IP Portfolio with Issuance of New U.S. Patent